The company announced today the publication of a study illustrating the unique and valuable characteristics that its FORE-SIGHT oximeter offers for the evaluation of patients with congestive heart failure and related conditions. The paper was published in the March/April 2012 issue of Congestive Heart Failure Journal and is titled “Initial Description of Cerebral Oximetry Measurement in Heart Failure Patients”. It was authored by Dr. Marc Silver and his colleagues at Advocate Christ Medical Center in Oak Lawn, Illinois.
The study, headed by Dr. Silver, compared cerebral oximetry levels and pulse oximetry readings in 30 patients with congestive heart failure. The doctors found that monitoring peripheral pulse oximetry was quite often not predictive of low cerebral oximetry values.
As Dr. Silver reported in the paper, “The interplay between lung function, heart function and cerebral oxygenation is a complicated one.” So the direct measurement of absolute cerebral oximetry values is absolutely necessary to provide unique information not available from other monitoring means. This study is a valuable tool for the sales force of CAS Medical when trying to sell the company’s FORE-SIGHT monitoring system.
For additional information about CAS Medical Systems and its products, please visit the company’s website at www.casmed.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
